The surprising value of fat: adipose tissue as a source of your own cells

Fat doesn't have a great reputation. But in 2001, researchers reported something unexpected: the fatty tissue removed during liposuction contained cells that behaved much like the mesenchymal stem cells long studied in bone marrow. That finding opened a new chapter in regenerative science, and made adipose tissue one of the most studied sources of autologous cells.

Fat is an active tissue

Adipose tissue is not simply stored energy. It's an active organ that produces hormones, cushions the body, and has an extensive network of small blood vessels. Along those vessels live a population of cells now called adipose-derived stem cells (ASCs). Like other mesenchymal cells, they can adhere to lab surfaces, multiply, and (under the right conditions) develop into bone, cartilage, or fat cells.

What makes fat stand out is quantity. Gram for gram, adipose tissue is often reported to hold far more mesenchymal cells than bone marrow, by some estimates hundreds of times more. That's why it's frequently described as the richest source of these cells that can be reached with a minor procedure.

How it's collected: the mini-liposuction

Collecting fat for cell research looks very different from cosmetic liposuction. It's a much smaller procedure:

1. The area, usually the abdomen or flank, is numbed with a local anesthetic.
2. A thin cannula is inserted through a tiny incision.
3. A small sample of fat, often a few tablespoons to a few ounces, is gently drawn out.
4. The site is bandaged, and most people return to light activity quickly, with some bruising or soreness for a few days.

Two things fat can yield

Adipose-derived stem cells (ASCs) are the mesenchymal cells themselves, prized for their signaling activity and their ability to differentiate.

Stromal vascular fraction (SVF) is a broader mix. When fat is processed to remove the fat cells, what remains is a blend of ASCs, cells from blood vessel walls, immune cells, and other supporting cells. Some researchers believe this mixture works as a team, and that its variety may be part of its appeal.

The same tissue many people would happily lose turns out to hold one of the body's largest reserves of repair-signaling cells.

Where the research stands

Adipose-derived cells have been studied in knee osteoarthritis, tendon and ligament injuries, wound healing, and a range of other areas. Early-phase trials have generally reported acceptable safety, and some have reported improvements in pain and function. Many studies are small, though, and larger controlled trials are still needed to answer how well these cells work, for whom, and how best to prepare them.

The regulatory side is also important. In the U.S., the FDA treats many processed fat-derived cell products, particularly SVF isolated with enzymes, as drugs that require approval. Most of these uses remain investigational. That's one reason reputable providers are careful about how they describe what these cells can and cannot do.

How fat compares

Compared with blood, fat yields true mesenchymal cells rather than mainly platelets and signals. Compared with bone marrow, it's typically easier to collect in larger quantities. Bone marrow, however, has the longest research track record in orthopedics, which is the subject of our next article.

Medical Disclaimer: This article is for educational purposes only. Autologous cell therapy using adipose tissue is investigational in the U.S., and published results vary. Always consult a qualified healthcare provider before pursuing any treatment.